SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001513162-23-000131
Filing Date
2023-08-18
Accepted
2023-08-18 16:25:17
Documents
1
Period of Report
2022-12-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2015
  Complete submission text file 0001513162-23-000131.txt   3684
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9493792875
BIOMERICA INC (Issuer) CIK: 0000073290 (see all company filings)

IRS No.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O OBALON THERAPEUTICS, INC. 5421 AVENIDA ENCINAS, SUITE F CARLSBAD CA 92008
Business Address
MOATAZEDI DAVID (Reporting) CIK: 0001700836 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37863 | Film No.: 231186157